Showing 3141-3150 of 18626 results for "".
Main Findings and Implications of "Cost Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease" Study
https://reachmd.com/programs/clinicians-roundtable/main-findings-and-implications-of-study/771/What is the Cost Effectiveness of High-Dose Statin Therapy in High-Risk Patients with Coronary Artery Disease? Recent clinical trials found that high-dose statin therapy, compared with conventional-dose statin therapy, reduces the risk of cardiovascular events in patients with acute coronary syndromAn MD's Insight in the Development of Treatments
https://reachmd.com/programs/clinicians-roundtable/an-mds-insight-in-the-development-of-treatments/713/Dr. Berlant tells about his experience in helping to develop a treatment for PTSD.Women's Healthcare Issues
https://reachmd.com/programs/clinicians-roundtable/womens-healthcare-issues/122/Dr. Maureen Lowery discusses some of the challenges for women today in taking care of their own health and how doctors can address some of women's needs within their practices.Effective MIGS for Optimal IOP Control: A Case-Based Approach
https://reachmd.com/programs/cme/effective-migs-for-optimal-iop-control-a-case-based-approach/32251/Watch our experts discuss new technologies and new therapies that are advancing the management of patients with glaucoma.Reducing the ALS Diagnostic Delay: The Impacts of a Rapid Access Clinic
https://reachmd.com/programs/neurofrontiers/reducing-the-als-diagnostic-delay-the-impacts-of-a-rapid-access-clinic/26389/Here’s how a rapid access clinic is minimizing the diagnostic delay for patients suspected of having ALS.The Immune System’s Role in Chronic Cases of Atopic Dermatitis
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/derm-hub/37143/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, a board-certified dermatologist in San Diego, California, and Director of Clinical Dermatology at Therapeutics Clinical Research, talks about reconciling the roles of Th2, Th22, and Th17 pathways in atopic dermatitis phenotypes, especIdentifying Individualized Treatment Approaches for EOE Patients
https://reachmd.com/programs/gi-insights/identifying-individualized-treatment-approaches-for-eoe-patients/15394/There are several therapies for EOE, but not one algorithm fits every patient. Tune in to learn more about finding the right treatment for your patient.Evaluating the Increasing Incidence of Eosinophilic Esophagitis: What You Need to Know
https://reachmd.com/programs/gi-insights/evaluating-the-increasing-incidence-of-eosinophilic-esophagitis-what-you-need-to-know/13748/Eosinophilic esophagitis is on the rise. Can we stop these growing rates by adjusting our treatment approach?ASCVD Risk & Women: Investigating Impact on Female Patients
https://reachmd.com/programs/heart-matters/ascvd-risk-women-investigating-impact-on-female-patients/12589/If cardiovascular disease remains the leading cause of death in women, what are some of the risks we should be discussing with our patients?Navigating the Intersection of Antithrombotic Therapy & GI Bleeding
https://reachmd.com/programs/gi-insights/navigating-the-intersection-of-antithrombotic-therapy-gi-bleeding/12453/What should we do when the use of antithrombotics like anticoagulants and antiplatelet therapies overlap with GI bleeding?